Skip to main content
PMC home page
The Journal of Experimental Medicine logoLink to The Journal of Experimental Medicine
. 1988 Mar 1;167(3):853–872. doi: 10.1084/jem.167.3.853

Functional polymorphism of each of the two HLA-DR beta chain loci demonstrated with antigen-specific DR3- and DRw52-restricted T cell clones

PMCID: PMC2188901  PMID: 2450955

Abstract

HLA-DR3- and HLA-DRw52-associated functional polymorphism was investigated with selected tetanus toxoid (TT)-specific T cell clones. We have shown earlier that HLA-DR antigens are encoded by two distinct loci, DR beta I and DR beta III. The alloantigenic determinant(s) defined by the serological HLA-DR3 specificity map to the former, while the supratypic HLA-DRw52 determinants map to DR beta III. Furthermore, we have recently recognized by DNA sequencing three alleles of HLA- DRw52 at locus DR beta III, referred to as 52 a, b, and c. Our objective was to correlate the pattern of T cell restriction with the gene products of individual DR beta chain loci and with the three newly described alleles of locus DR beta III. Among the selected T cell clones, 5 reacted exclusively when TT was presented by HLA-DR3+ APCs (TT-DR3-APC). In contrast, two T cell clones were stimulated by TT- DRw52-APC. More specifically, these two T cell clones (Clones 10 and 16) were stimulated by different subsets of TT-DRw52-APC. Clone 16 responded to some DR3 and TT-DRw6-APC, while clone 10 was stimulated by other TT-DR3 and TT-DRw6, and all TT-DR5-APC. This same pattern of DRw52 restriction was found in panel, as well as in family studies. Because this suggested a correlation with the pattern of DRw52 polymorphism observed earlier by DNA sequencing and oligonucleotide hybridization, the APC used in these experiments were typed for the 52 a, b, and c alleles of locus DR beta III by allele-specific oligonucleotide probes. This distribution overlapped exactly with the stimulation pattern defined by the T cell clones. Clone 16 responded to TT-52a-APC, clone 10 to TT-52b-APC, and both clones to a TT-52c-APC. The response of the T cell clones was inhibited differentially by mAbs to DR. Raising TT concentration, or increasing HLA-class II expression with INF-gamma both affected the magnitude of response of the TT- specific clones but did not modify their specificities. These results demonstrate that a restriction specificity can be attributed to the DR beta III locus and illustrate the functional relevance of the polymorphism observed at this locus. This is of special interest in view of the striking difference in the pattern of structural diversity among alleles of DR beta I and DR beta III.

Full Text

The Full Text of this article is available as a PDF (1.4 MB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Angelini G., de Preval C., Gorski J., Mach B. High-resolution analysis of the human HLA-DR polymorphism by hybridization with sequence-specific oligonucleotide probes. Proc Natl Acad Sci U S A. 1986 Jun;83(12):4489–4493. doi: 10.1073/pnas.83.12.4489. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Bell J. I., Denney D., Jr, Foster L., Belt T., Todd J. A., McDevitt H. O. Allelic variation in the DR subregion of the human major histocompatibility complex. Proc Natl Acad Sci U S A. 1987 Sep;84(17):6234–6238. doi: 10.1073/pnas.84.17.6234. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Berdoz J., Gorski J., Termijtelen A. M., Dayer J. M., Irlé C., Schendel D., Mach B. Constitutive and induced expression of the individual HLA-DR beta and alpha chain loci in different cell types. J Immunol. 1987 Aug 15;139(4):1336–1341. [PubMed] [Google Scholar]
  4. Bontrop R., Ottenhoff T., Van Miltenburg R., Elferink D., De Vries R., Giphart M. Quantitative and qualitative differences in HLA-DR molecules correlated with antigen-presentation capacity. Eur J Immunol. 1986 Feb;16(2):133–138. doi: 10.1002/eji.1830160205. [DOI] [PubMed] [Google Scholar]
  5. Bontrop R., Tilanus M., Mikulski M., van Eggermond M., Termijtelen A., Giphart M. Polymorphisms within the HLA-DR3 haplotypes. I. HLA-DR polymorphisms detected at the protein and DNA levels are reflected by T-cell recognition. Immunogenetics. 1986;23(6):401–405. doi: 10.1007/BF00372674. [DOI] [PubMed] [Google Scholar]
  6. Brown M. A., Glimcher L. A., Nielsen E. A., Paul W. E., Germain R. N. T-cell recognition of Ia molecules selectively altered by a single amino acid substitution. Science. 1986 Jan 17;231(4735):255–258. doi: 10.1126/science.3484558. [DOI] [PubMed] [Google Scholar]
  7. Buus S., Sette A., Colon S. M., Miles C., Grey H. M. The relation between major histocompatibility complex (MHC) restriction and the capacity of Ia to bind immunogenic peptides. Science. 1987 Mar 13;235(4794):1353–1358. doi: 10.1126/science.2435001. [DOI] [PubMed] [Google Scholar]
  8. Böhme J., Andersson M., Andersson G., Möller E., Peterson P. A., Rask L. HLA-DR beta genes vary in number between different DR specificities, whereas the number of DQ beta genes is constant. J Immunol. 1985 Sep;135(3):2149–2155. [PubMed] [Google Scholar]
  9. Carrel S., Tosi R., Gross N., Tanigaki N., Carmagnola A. L., Accolla R. S. Subsets of human Ia-like molecules defined by monoclonal antibodies. Mol Immunol. 1981 May;18(5):403–411. doi: 10.1016/0161-5890(81)90102-4. [DOI] [PubMed] [Google Scholar]
  10. Cohn L. E., Glimcher L. H., Waldmann R. A., Smith J. A., Ben-Nun A., Seidman J. G., Choi E. Identification of functional regions on the I-Ab molecule by site-directed mutagenesis. Proc Natl Acad Sci U S A. 1986 Feb;83(3):747–751. doi: 10.1073/pnas.83.3.747. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Eckels D. D., Hartzman R. J. Characterization of human T-lymphocyte clones (TLCs) specific for HLA-region gene products. Immunogenetics. 1982;16(2):117–133. doi: 10.1007/BF00364399. [DOI] [PubMed] [Google Scholar]
  12. Geppert T. D., Lipsky P. E. Antigen presentation by interferon-gamma-treated endothelial cells and fibroblasts: differential ability to function as antigen-presenting cells despite comparable Ia expression. J Immunol. 1985 Dec;135(6):3750–3762. [PubMed] [Google Scholar]
  13. Gorski J., Tilanus M., Giphart M., Mach B. Oligonucleotide genotyping shows that alleles at the HLA-DR beta III locus of the DRw52 supertypic group segregate independently of known DR or Dw specificities. Immunogenetics. 1987;25(2):79–83. doi: 10.1007/BF00364271. [DOI] [PubMed] [Google Scholar]
  14. Gorski J., Tosi R., Strubin M., Rabourdin-Combe C., Mach B. Serological and immunochemical analysis of the products of a single HLA DR-alpha and DR-beta chain gene expressed in a mouse cell line after DNA-mediated cotransformation reveals that the beta chain carries a known supertypic specificity. J Exp Med. 1985 Jul 1;162(1):105–116. doi: 10.1084/jem.162.1.105. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Griffith I. J., Choi E. M., Glimcher L. H. A single base mutation in an I-A alpha-chain gene alters T-cell recognition. Proc Natl Acad Sci U S A. 1987 Feb;84(4):1090–1093. doi: 10.1073/pnas.84.4.1090. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Gross-Bellard M., Oudet P., Chambon P. Isolation of high-molecular-weight DNA from mammalian cells. Eur J Biochem. 1973 Jul 2;36(1):32–38. doi: 10.1111/j.1432-1033.1973.tb02881.x. [DOI] [PubMed] [Google Scholar]
  17. Guillet J. G., Lai M. Z., Briner T. J., Buus S., Sette A., Grey H. M., Smith J. A., Gefter M. L. Immunological self, nonself discrimination. Science. 1987 Feb 20;235(4791):865–870. doi: 10.1126/science.2433769. [DOI] [PubMed] [Google Scholar]
  18. Guillet J. G., Lai M. Z., Briner T. J., Smith J. A., Gefter M. L. Interaction of peptide antigens and class II major histocompatibility complex antigens. Nature. 1986 Nov 20;324(6094):260–262. doi: 10.1038/324260a0. [DOI] [PubMed] [Google Scholar]
  19. Johnson J. P., Meo T., Riethmüller G., Schendel D. J., Wank R. Direct demonstration of an HLA-DR allotypic determinant on the low molecular weight (beta) subunit using a mouse monoclonal antibody specific for DR3. J Exp Med. 1982 Jul 1;156(1):104–111. doi: 10.1084/jem.156.1.104. [DOI] [PMC free article] [PubMed] [Google Scholar]
  20. Koning F., Schreuder I., Giphart M., Bruning H. A mouse monoclonal antibody detecting a DR-related MT2-like specificity: serology and biochemistry. Hum Immunol. 1984 Apr;9(4):221–230. doi: 10.1016/0198-8859(84)90027-2. [DOI] [PubMed] [Google Scholar]
  21. Kourilsky P., Chaouat G., Rabourdin-Combe C., Claverie J. M. Working principles in the immune system implied by the "peptidic self" model. Proc Natl Acad Sci U S A. 1987 May;84(10):3400–3404. doi: 10.1073/pnas.84.10.3400. [DOI] [PMC free article] [PubMed] [Google Scholar]
  22. Londei M., Lamb J. R., Bottazzo G. F., Feldmann M. Epithelial cells expressing aberrant MHC class II determinants can present antigen to cloned human T cells. Nature. 1984 Dec 13;312(5995):639–641. doi: 10.1038/312639a0. [DOI] [PubMed] [Google Scholar]
  23. Long E. O., Wake C. T., Strubin M., Gross N., Accolla R. S., Carrel S., Mach B. Isolation of distinct cDNA clones encoding HLA-DR beta chains by use of an expression assay. Proc Natl Acad Sci U S A. 1982 Dec;79(23):7465–7469. doi: 10.1073/pnas.79.23.7465. [DOI] [PMC free article] [PubMed] [Google Scholar]
  24. Mach B., Gorski J., Rollini P., Berte C., Amaldi I., Berdoz J., Ucla C. Polymorphism and regulation of HLA class II genes of the major histocompatibility complex. Cold Spring Harb Symp Quant Biol. 1986;51(Pt 1):67–74. doi: 10.1101/sqb.1986.051.01.009. [DOI] [PubMed] [Google Scholar]
  25. Myers L. K., Ball E. J., Nuñez G., Stastny P. Recognition of class II molecules by human T cells. I. Analysis of epitopes of DR and DQ molecules in a DRw11, DRw52, DQw3 haplotype. Immunogenetics. 1986;23(3):142–150. doi: 10.1007/BF00373814. [DOI] [PubMed] [Google Scholar]
  26. Nepom G. T., Nepom B. S., Antonelli P., Mickelson E., Silver J., Goyert S. M., Hansen J. A. The HLA-DR4 family of haplotypes consists of series of distinct DR and DS molecules. J Exp Med. 1984 Feb 1;159(2):394–404. doi: 10.1084/jem.159.2.394. [DOI] [PMC free article] [PubMed] [Google Scholar]
  27. Ottenhoff T. H., Elferink D. G., Hermans J., de Vries R. R. HLA class II restriction repertoire of antigen-specific T cells. I. The main restriction determinants for antigen presentation are associated with HLA-D/DR and not with DP and DQ. Hum Immunol. 1985 Jun;13(2):105–116. doi: 10.1016/0198-8859(85)90017-5. [DOI] [PubMed] [Google Scholar]
  28. Ottenhoff T. H., Elferink D. G., Termijtelen A., Koning F., de Vries R. R. HLA class II restriction repertoire of antigen-specific T cells. II. Evidence for a new restriction determinant associated with DRw52 and LB-Q1. Hum Immunol. 1985 Jun;13(2):117–123. doi: 10.1016/0198-8859(85)90018-7. [DOI] [PubMed] [Google Scholar]
  29. Qvigstad E., Gaudernack G., Thorsby E. Antigen-specific T cell clones restricted by DR, DRw53 (MT), or DP (SB) Class II HLA molecules. Inhibition studies with monoclonal HLA-specific antibodies. Hum Immunol. 1984 Dec;11(4):207–217. doi: 10.1016/0198-8859(84)90060-0. [DOI] [PubMed] [Google Scholar]
  30. Rollini P., Mach B., Gorski J. Linkage map of three HLA-DR beta-chain genes: evidence for a recent duplication event. Proc Natl Acad Sci U S A. 1985 Nov;82(21):7197–7201. doi: 10.1073/pnas.82.21.7197. [DOI] [PMC free article] [PubMed] [Google Scholar]
  31. Schwartz R. H. Antigen presentation: fugue in T-lymphocyte recognition. Nature. 1987 Apr 23;326(6115):738–739. doi: 10.1038/326738a0. [DOI] [PubMed] [Google Scholar]
  32. Termijtelen A., Tilanus M. G., Engelen I., Koning F., van Rood J. J. Molecular localization of LB-Q1, a DRw52-like T-cell recognition epitope and identification at the genomic level of associated shared hybridizing fragments. Hum Immunol. 1987 Aug;19(4):255–267. doi: 10.1016/0198-8859(87)90043-7. [DOI] [PubMed] [Google Scholar]
  33. Tosi R., Tanigaki N., De Préval C., Gorski J., Mach B. Immunochemical analysis of a cell transfected with an HLA-DR gene reveals a new alloantigenic specificity within HLA-DRw52. Eur J Immunol. 1986 Dec;16(12):1603–1608. doi: 10.1002/eji.1830161221. [DOI] [PubMed] [Google Scholar]
  34. Triebel F., Missenard-Leblond V., Couty M. C., Charron D. J., Debre P. Differential inhibition of human antigen-specific T cell clone proliferative responses by distinct monoclonal anti-HLA-DR antibodies. J Immunol. 1984 Apr;132(4):1773–1778. [PubMed] [Google Scholar]
  35. Unanue E. R., Allen P. M. The basis for the immunoregulatory role of macrophages and other accessory cells. Science. 1987 May 1;236(4801):551–557. doi: 10.1126/science.2437650. [DOI] [PubMed] [Google Scholar]
  36. Watson A. J., DeMars R., Trowbridge I. S., Bach F. H. Detection of a novel human class II HLA antigen. 1983 Jul 28-Aug 3Nature. 304(5924):358–361. doi: 10.1038/304358a0. [DOI] [PubMed] [Google Scholar]
  37. Ziegler A., Heinig J., Müller C., Götz H., Thinnes F. P., Uchańska-Ziegler B., Wernet P. Analysis by sequential immunoprecipitations of the specificities of the monoclonal antibodies TU22,34,35,36,37,39,43,58 and YD1/63.HLK directed against human HLA class II antigens. Immunobiology. 1986 Mar;171(1-2):77–92. doi: 10.1016/S0171-2985(86)80019-5. [DOI] [PubMed] [Google Scholar]

Articles from The Journal of Experimental Medicine are provided here courtesy of The Rockefeller University Press

RESOURCES